Cabaletta Bio (CABA) Stock Price, Quote, News & History | Benzinga

Cabaletta Bio Inc (CABA) Stock Price, Quote, News & History

CABANASDAQ

Trade with Public

Trade with Public

$3.51

-0.07-1.96%

At close: Jun 3, 5:00 PM EST

$3.52

-0.06-1.68%

Pre-Market: 8:45 AM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$3.51

Volume / Avg.

6.87K / 3.08M

Day Range

- - -

52 Wk Range

1.26 - 4.23

Market Cap

$573.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

15.51%

Days to Cover

3.25

Recent Cabaletta Bio Inc News

FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.

Vandana Singh

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

Vinay Prasad exits FDA's biologics division following pressure over Sarepta's Elevidys approval and regulatory controversies.

Vandana Singh

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers

FDA lifts REMS for approved CAR-T therapies, easing hospital restrictions and signaling broader future access in oncology and autoimmune treatment.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-142.84M

Investing Cash Flow (TTM)

1.48M

Financing Cash Flow (TTM)

126.17M

Free Cash Flow (TTM)

-143.28M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-15.19M

Analyst Trends and Forecast

2

Mar

1

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$506.60M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

5.54

Earnings Yield % (TTM)

-50.71%

Earnings Yield % (FWD)

-43.02%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.63

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$9.98M

Total Cash

$116.64M

Debt to Equity

0.26

Issuance of Debt (TTM)

-$9.98M

Repayment of Debt (TTM)

-$9.98M

Key Statistics

Open

-

Close

$3.51

Volume / Avg.

6.87K / 3.08M

Day Range

- - -

52 Wk Range

1.26 - 4.23

Market Cap

$573.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

15.51%

Days to Cover

3.25

About

Sector

Health Care

Industry

Biotechnology

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Cabaletta Bio (CABA) stock?

A

You can purchase shares of Cabaletta Bio (NASDAQ:CABA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cabaletta Bio (CABA) competitors?

A

There are no as such competitors for Cabaletta Bio.

Q

What is the forecast, or price target, for Cabaletta Bio (CABA) stock?

A

Cabaletta Bio has a consensus price target of $20.00.

Q

What is the current price for Cabaletta Bio (CABA)?

A

The stock price for Cabaletta Bio (NASDAQ: CABA) is $3.52 last updated June 5, 2026 at 9:11 AM EDT.

Q

Does Cabaletta Bio (CABA) pay a dividend?

A

There are no upcoming dividends for Cabaletta Bio.

Q

When is Cabaletta Bio (NASDAQ:CABA) reporting earnings?

A

Cabaletta Bio does not have any upcoming earnings scheduled.

Q

Is Cabaletta Bio (CABA) going to split?

A

There is no upcoming split for Cabaletta Bio.

Q

What sector and industry does Cabaletta Bio (CABA) operate in?

A

Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.